Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lubrinase NS is a nasal moisturizing spray developed and marketed by Entod Pharmaceuticals. It is formulated with sodium chloride (typically 0.65% w/v) and glycerin to provide relief from nasal dryness, irritation, and crusting. The product acts as a humectant and lubricant, hydrating the nasal mucosa and thinning thick mucus, which facilitates easier breathing and improves ciliary clearance. It is commonly used for dryness caused by low humidity, environmental pollutants, allergies, or as a supportive treatment for chronic rhinitis and sinusitis. By maintaining moisture in the nasal passages, it helps prevent the formation of painful crusts and supports the natural protective barrier of the respiratory epithelium.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium chloride + glycerin.